Order from Altium

The order placed by Altium, amounting to a total value of approximately EUR 460 K, is expected to be shipped in December 2024, meaning that this is assessed to be recognized in the Company’s Q3-report for the fiscal year 2024/2025. The order is a part of the existing distribution agreement that PHI and Altium entered into in November 2023 and is within the frames of the order agreement regarding 20 HoloMonitor® systems that was communicated in September 2024. Altium has a wide network around the globe and thus potential to broaden the market access for PHI’s products extensively. Over the last year, Altium has subcontracted various resellers and opened up many new markets for PHI.

Sales outlook for PHI

PHI’s fiscal year runs from 1 May until 30 April, resulting in a third quarter stemming from November through January and a fourth quarter from February through April. Given the distribution agreement with Altium, PHI and Altium have spent the first two quarters of the fiscal year 2024/2025 focusing on doing the groundwork and laying a foundation of the collaboration, as well as training and supporting the subcontractors of Altium. Whereas sales numbers have taken a small hit in the first two quarters this fiscal year, PHI expects for the laid work and extensive collaboration to yield improved results and show significant achievements in the quarters ahead, securing long-term growth. The orders now placed by Altium will contribute to a strong third quarter, and the total expected order value from Altium for the full fiscal year of 2024/2025 is estimated to amount to approximately EUR 2 million.

Goran Dubravčić, Chairman of PHI and CEO of Altium, comments

“Altium experiences a high demand for PHI’s products, and with our knowledge and experience of the market for these types of products, we expect this order flow to continue going forward. The further upgraded versions of the HoloMonitor® in the coming years will, in our view, open up even more possibilities and attract more interest, leading to further business.”

Anders Månsson, CEO of PHI, comments

“PHI has, in the first and second quarter of 2024/2025, spent the majority of time focusing on establishing the collaboration between PHI and Altium and educating Altium’s sales personnel and subcontractors in the HoloMonitor® systems. With the orders made by Altium, totalling a significant value, we can start to see the work put in paying off, and this is what we expect in future quarters as well.”

This disclosure contains information that Phase Holographic is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 02-12-2024 08:40 CET.

For additional information, please contact:
Anders Månsson
E-mail: ir@phiab.com
Web: www.phiab.com – Live cell imaging & analysis

About PHI
Phase Holographic Imaging (PHI) is a medical technology company that develops and markets its non-invasive time-lapse imaging instruments for long-term quantitative analysis of living cells. The foundation of PHI’s current commercial HoloMonitor® products is Quantitative Phase Imaging (QPI) technology — an innovative approach to cell quality evaluation. QPI offers detailed analysis of cell characteristics without harming the cells, avoiding the limitations of traditional measurement methods. PHI is actively focusing on business development to expand from pre-clinical research to the clinical market and the emerging regenerative medicine field. PHI envisions transforming live cell analysis and establishing QPI as a standard for cell quality control, making future cell therapies safe, affordable, and accessible for patients. PHI is based in Lund, Sweden, Boston, MA and Winston-Salem, NC.